Adaptive Clinical Trial Design: Has Its Time Come?
نویسندگان
چکیده
منابع مشابه
Adaptive clinical trial design: has its time come?
O ne of the most talked-about cancer clinical trials last spring was BATTLE — a phase II trial that did not change practice or introduce a new drug. What got all the attention was the non-small cell lung cancer trial’s “adaptive” design. In adaptive trials, data gathered as the trial progresses are used to change some aspect of the trial midstream. These trials have increased over the past deca...
متن کاملClinical Trial Registration: The Time Has Come….
Note from the AJOT Editor-in-Chief: AJOT has joined several other major rehabilitation and disability journals in a collaborative initiative to mandate clinical trial registration. Authors of manuscripts reporting clinical trials must ensure that the trials are registered before submitting their manuscript. For trials that are underway and are already enrolling patients, registration will be re...
متن کاملHarmonization: Its Time Has Come.
The importance of standardization of laboratory test results has a long history traceable to the first proficiency testing results in 1947 that demonstrated large discrepancies among results from 59 hospital laboratories (1 ). The AACC published a series of monographs in 1953– 1972 titled Standard Methods of Clinical Chemistry that promoted a single measurement procedure (MP) for a measurand. T...
متن کاملRun-Time Parallelization: Its Time Has Come
Current parallelizing compilers cannot identify a significant fraction of parallelizable loops because they have complex or statically insufficiently defined access patterns. This type of loop mostly occurs in irregular, dynamic applications which represent more than 50% of all applications [20]. Making parallel computing succeed has therefore become conditioned by the ability of compilers to a...
متن کاملLung cancer screening: has its time come?
Reflecting lung cancer screening’s potential for complexity, the article in this issue by Drs. Brawley and Flenaugh points out that there are so many different solitary nodules found on the low-dose helical computerized tomography (LDCT) used for lung cancer screening that algorithms are being developed to more effectively and accurately distinguish benign lesions from malignant ones. The major...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2010
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djq319